JA Lust
Impact in
- Hematology top 2%
- Multiple Myeloma Research and Treatments
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Multiple Myeloma Research and Treatments 8
- Genetics 7
- Chronic Lymphocytic Leukemia Research 4
- Myeloproliferative Neoplasms: Diagnosis and Treatment 2
- Co-authors
- PR Greipp (4 shared papers)Ayalew Tefferi (2 shared papers)CY Li (2 shared papers)RL Phyliky (2 shared papers)TE Witzig (3 shared papers)RA Kyle (4 shared papers)JA Katzmann (2 shared papers)W. Michael O’Fallon (1 shared paper)
- Journals
- Blood (6 papers)Haematologica (2 papers)Leukemia (1 paper)PubMed (2 papers)Clinical Lymphoma & Myeloma (2 papers)
- Partner nations
- United StatesIreland
In The Last Decade
JA Lust
12 papers receiving 896 citations
Peers
Comparison fields: 5 of 50
- Hematology 599
- Genetics 346
- Oncology 370
- Pathology and Forensic Medicine 207
- Immunology 241
Countries citing papers authored by JA Lust
This map shows the geographic impact of JA Lust's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by JA Lust with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites JA Lust more than expected).
Fields of papers citing papers by JA Lust
This network shows the impact of papers produced by JA Lust. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by JA Lust. The network helps show where JA Lust may publish in the future.
Co-authors
The 25 scholars most cited alongside JA Lust, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1993 | 241 | |
| 2 | 1994 | 205 | |
| 3 | 1994 | 114 | |
| 4 | 1996 | 86 | |
| 5 | 1996 | 81 | |
| 6 | Epoetin alfa for the treatment of the anemia of multiple myeloma. A prospective, randomized, placebo-controlled, double-blind trial. | 1995 | 63 |
| 7 | Clinical parameters for determining when and when not to treat essential thrombocythemia. | 1999 | 50 |
| 8 | 2013 | 34 | |
| 9 | 1998 | 30 | |
| 10 | 2016 | 7 | |
| 11 | 1993 | 5 | |
| 12 | 2009 | 1 | |
| 13 | 2009 | 0 |
About JA Lust
JA Lust is a scholar working on Hematology, Genetics, Oncology, Molecular Biology and Immunology, having authored 13 papers that have together received 917 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (8 papers), Chronic Lymphocytic Leukemia Research (4 papers), Cancer Treatment and Pharmacology (3 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers), Immunodeficiency and Autoimmune Disorders (2 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (2 papers), Immune Cell Function and Interaction (2 papers) and Bone health and treatments (1 paper). The work is most often cited by research in Hematology (599 citations), Genetics (346 citations), Oncology (370 citations), Pathology and Forensic Medicine (207 citations) and Immunology (241 citations). JA Lust has collaborated with scholars based in United States and Ireland. Frequent co-authors include PR Greipp, Ayalew Tefferi, CY Li, RL Phyliky, TE Witzig, RA Kyle, JA Katzmann, W. Michael O’Fallon, MA Gertz and O'Fallon Wm. Their work appears in journals such as Blood, Haematologica, Leukemia, PubMed and Clinical Lymphoma & Myeloma.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.